Cargando…

Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma

[(18)F]FDG PET/MRI was shown to have limited sensitivity for N-staging in FIGO I/II cervical carcinoma. Therefore, this prospective study aimed to investigate the additional value of multiparametric dual-time-point PET/MRI and to assess potential influencing factors for lymph node metastasis (LNM) d...

Descripción completa

Detalles Bibliográficos
Autores principales: Weissinger, Matthias, Kommoss, Stefan, Jacoby, Johann, Ursprung, Stephan, Seith, Ferdinand, Hoffmann, Sascha, Nikolaou, Konstantin, Brucker, Sara Yvonne, La Fougère, Christian, Dittmann, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456388/
https://www.ncbi.nlm.nih.gov/pubmed/36078873
http://dx.doi.org/10.3390/jcm11174943
_version_ 1784785803390484480
author Weissinger, Matthias
Kommoss, Stefan
Jacoby, Johann
Ursprung, Stephan
Seith, Ferdinand
Hoffmann, Sascha
Nikolaou, Konstantin
Brucker, Sara Yvonne
La Fougère, Christian
Dittmann, Helmut
author_facet Weissinger, Matthias
Kommoss, Stefan
Jacoby, Johann
Ursprung, Stephan
Seith, Ferdinand
Hoffmann, Sascha
Nikolaou, Konstantin
Brucker, Sara Yvonne
La Fougère, Christian
Dittmann, Helmut
author_sort Weissinger, Matthias
collection PubMed
description [(18)F]FDG PET/MRI was shown to have limited sensitivity for N-staging in FIGO I/II cervical carcinoma. Therefore, this prospective study aimed to investigate the additional value of multiparametric dual-time-point PET/MRI and to assess potential influencing factors for lymph node metastasis (LNM) detection. A total of 63 patients underwent whole-body dual-time-point [(18)F]FDG PET/MRI 60 + 90 min p.i., and 251 LN were evaluated visually, quantified multiparametrically, and correlated with histology. Grading of the primary tumor (G2/G3) had a significant impact on visual detection (sens: 8.3%/31%). The best single parameter for LNM detection was SUVavg, however, with a significant loss of discriminatory power in G2 vs. G3 tumors (AUC: 0.673/0.901). The independent predictors SUVavg, ∆SUVpeak, LN sphericity, ADC, and histologic grade were included in the logistic-regression-based malignancy score (MS) for multiparametric analysis. Application of MS enhanced AUCs, especially in G2 tumors (AUC: G2:0.769; G3:0.877) and improved the accuracy for single LNM from 34.5% to 55.5% compared with the best univariate parameter SUVavg. Compared with visual analysis, the use of the malignancy score increased the overall sensitivity from 31.0% to 79.3% (Youden optimum) with a moderate decrease in specificity from 98.3% to 75.6%. These findings indicate that multiparametric evaluation of dual-time-point PET/MRI has the potential to improve accuracy compared with visual interpretation and enables sufficient N-staging also in G2 cervical carcinoma.
format Online
Article
Text
id pubmed-9456388
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94563882022-09-09 Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma Weissinger, Matthias Kommoss, Stefan Jacoby, Johann Ursprung, Stephan Seith, Ferdinand Hoffmann, Sascha Nikolaou, Konstantin Brucker, Sara Yvonne La Fougère, Christian Dittmann, Helmut J Clin Med Article [(18)F]FDG PET/MRI was shown to have limited sensitivity for N-staging in FIGO I/II cervical carcinoma. Therefore, this prospective study aimed to investigate the additional value of multiparametric dual-time-point PET/MRI and to assess potential influencing factors for lymph node metastasis (LNM) detection. A total of 63 patients underwent whole-body dual-time-point [(18)F]FDG PET/MRI 60 + 90 min p.i., and 251 LN were evaluated visually, quantified multiparametrically, and correlated with histology. Grading of the primary tumor (G2/G3) had a significant impact on visual detection (sens: 8.3%/31%). The best single parameter for LNM detection was SUVavg, however, with a significant loss of discriminatory power in G2 vs. G3 tumors (AUC: 0.673/0.901). The independent predictors SUVavg, ∆SUVpeak, LN sphericity, ADC, and histologic grade were included in the logistic-regression-based malignancy score (MS) for multiparametric analysis. Application of MS enhanced AUCs, especially in G2 tumors (AUC: G2:0.769; G3:0.877) and improved the accuracy for single LNM from 34.5% to 55.5% compared with the best univariate parameter SUVavg. Compared with visual analysis, the use of the malignancy score increased the overall sensitivity from 31.0% to 79.3% (Youden optimum) with a moderate decrease in specificity from 98.3% to 75.6%. These findings indicate that multiparametric evaluation of dual-time-point PET/MRI has the potential to improve accuracy compared with visual interpretation and enables sufficient N-staging also in G2 cervical carcinoma. MDPI 2022-08-23 /pmc/articles/PMC9456388/ /pubmed/36078873 http://dx.doi.org/10.3390/jcm11174943 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Weissinger, Matthias
Kommoss, Stefan
Jacoby, Johann
Ursprung, Stephan
Seith, Ferdinand
Hoffmann, Sascha
Nikolaou, Konstantin
Brucker, Sara Yvonne
La Fougère, Christian
Dittmann, Helmut
Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma
title Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma
title_full Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma
title_fullStr Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma
title_full_unstemmed Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma
title_short Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma
title_sort multiparametric dual-time-point [(18)f]fdg pet/mri for lymph node staging in patients with untreated figo i/ii cervical carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456388/
https://www.ncbi.nlm.nih.gov/pubmed/36078873
http://dx.doi.org/10.3390/jcm11174943
work_keys_str_mv AT weissingermatthias multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma
AT kommossstefan multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma
AT jacobyjohann multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma
AT ursprungstephan multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma
AT seithferdinand multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma
AT hoffmannsascha multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma
AT nikolaoukonstantin multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma
AT bruckersarayvonne multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma
AT lafougerechristian multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma
AT dittmannhelmut multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma